Tagus 10 mg (Tablet (Enteric Coated))

ProductTitle

• Tagus Gastro-resistant tablets

ProductCategory

• Medicine
• Gastrointestinal Health

Indications

• Active duodenal ulcer
• Active benign gastric ulcer
• Symptomatic erosive or ulcerative gastro-esophageal reflux disease (GERD)
• Gastro-esophageal Reflux Disease Long-term Management (GERD Maintenance)
• Symptomatic treatment of moderate to very severe gastro-esophageal reflux disease (symptomatic GERD)
• Zollinger-Ellison Syndrome
• In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori in patients with peptic ulcer disease

Pharmacology

• Suppresses gastric acid secretion by inhibiting the gastric H+/K+-ATPase at the secretory surface of the gastric parietal cell

Dosage

• 20 mg once daily in the morning for active duodenal ulcer and active benign gastric ulcer
• 20 mg once daily for four to eight weeks for erosive or ulcerative GERD
• 20 mg or 10 mg once daily for GERD maintenance
• 10 mg once daily for symptomatic treatment of moderate to very severe GERD
• 5 mg once daily for pediatric patients 1 to 11 years of age (Less than 15 kg)
• 10 mg once daily for pediatric patients 1 to 11 years of age (15 kg or more)
• 60 mg once a day for Zollinger-Ellison Syndrome
• 20 mg rabeprazole sodium twice daily, clarithromycin 500 mg twice daily, and amoxicillin 1g twice daily for eradication of H. pylori

Administration

• Should be taken in the morning, before eating, and swallowed whole

Interaction

• May interact with ketoconazole, itraconazole, atazanavir
• No interaction with liquid antacids observed

Contraindications

• Hypersensitivity to the active substance or to any of the excipients
• Contra-indicated in pregnancy and during breastfeeding

SideEffects

• Headache
• Diarrhoea
• Abdominal pain
• Vomiting
• Constipation
• Dry mouth
• Increased or decreased appetite
• Muscle pain
• Drowsiness
• Dizziness

PregnancyLactation

• US FDA pregnancy category 'C'
• Excretion in human milk
• Decision should be made whether to discontinue nursing or the drug, taking into account the importance of the drug to the mother

PrecautionsWarnings

• Symptomatic response does not preclude the presence of gastric or esophageal malignancy
• Regular surveillance for long-term treatment
• May increase the risk of hip, wrist, and spine fracture, particularly in the elderly
• Hypomagnesaemia reported in patients treated with PPIs for prolonged periods
• Reduced absorption of vitamin B12
• Possible association with subacute cutaneous lupus erythematosus (SCLE)
• Potential interference with laboratory tests

UseInSpecialPopulations

• No dosage adjustment for patients with renal or hepatic impairment
• Not recommended for use in children due to lack of data on safety and efficacy

OverdoseEffects

• Effects are generally minimal and reversible without further medical intervention
• No specific antidote known
• General supportive measures should be utilized

TherapeuticClass

• Proton Pump Inhibitor

StorageConditions

• Keep below 30°C temperature, away from light & moisture
• Keep out of the reach of children

ChemicalStructure

• Molecular Formula: C18H21N3O3S

CommonQuestions

• What is Tagus 10 mg Tablet?
• What is Tagus 10 mg Tablet used for?
• What are the side effects of Tagus 10 mg Tablet?
• How should I take Tagus 10 mg Tablet?
• Can I take Tagus 10 mg Tablet while pregnant or breastfeeding?
• What should I do if I overdose on Tagus 10 mg Tablet?
• How long should I take Tagus 10 mg Tablet?
• Is there anything else I should know about Tagus 10 mg Tablet?
• Does Tagus 10 mg Tablet cause bone problems?
• Can I take Tagus 10 mg Tablet with vitamin D?
• Quick Tips

Related Brands

• Tagus 20 mg (Tablet (Enteric Coated)) - healthcare-pharmaceuticals-ltd